课题基金 / 基金详情

PHASE I IDURD AND ACCELERATED HYPERFRACTIONATED XRT FOR HIGH GRADE GLIOMAS

PHASE I IDURD AND ACCELERATED HYPERFRACTIONATED XRT FOR HIGH GRADE GLIOMAS
针对高级别胶质瘤的 I期 IDURD 和加速超分割 XRT
批准号:
6121697
负责人:
JAMES A STEWART
金额:
$3.35万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

JAMES A STEWART的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Radiosensitization by the halogenated pyrimidine iododeoxyuridine (IdUrd) has been demonstrated in laboratory studies and is directly related to the percent thymidine replacement in DNA. This phase I study has been designed to assess the clinical feasibility of IdUrd as radiosensitizer when given with accelerated hyperfractionated radiotherapy (XRT) in the management of high grade gliomas. The IdUrd will be given as a 24 hour infusion over 28 consecutive days. The radiotherapy will be 60 Gy at 1.2 Gy per fraction twice a day for fifty fractions with concomitant, reduced volume boost of 10 Gy at 2 Gy per fraction once a week for five fractions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Data and Safety Monitoring
  • 批准号:
    8250424
  • 项目类别:
  • 资助金额:
    $12.54万
  • 财政年份:
    2011
  • 负责人:
    JAMES A STEWART
  • 依托单位:
Data and Safety Monitoring
  • 批准号:
    7491903
  • 项目类别:
  • 资助金额:
    $11.44万
  • 财政年份:
    2007
  • 负责人:
    JAMES A STEWART
  • 依托单位:
PHASE II TRIAL OF TWO DOSE LEVELS OF CCI-779 IN EXTENSIVE-STAGE SCLC
  • 批准号:
    7204343
  • 项目类别:
  • 资助金额:
    $0.04万
  • 财政年份:
    2005
  • 负责人:
    JAMES A STEWART
  • 依托单位:
HIGH-DOSE IFN-ALPHA-2B VS CISPLATIN, VINBLASTINE, DTIC + IL-2 & IFN IN MELANOMA
  • 批准号:
    7204326
  • 项目类别:
  • 资助金额:
    $1.8万
  • 财政年份:
    2005
  • 负责人:
    JAMES A STEWART
  • 依托单位:
海外基金